Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Landos Biopharma, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +2 vs. Q2 2021
- Shares held
- 22.7M
- −39.0K (−0.2%) vs. Q2 2021
- Total value
- $331.1M
- +$69.6M (+26.6%) vs. Q2 2021
- New holders
- 5
- 10 more added
- Sold out
- 3
- 15 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LABP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 16 | $34.9M |
| Q4 2023 | 10 | $5.58M |
| Q3 2023 | 11 | $5.93M |
| Q2 2023 | 8 | $6.27M |
| Q1 2023 | 20 | $4.63M |
| Q4 2022 | 23 | $7.87M |
| Q3 2022 | 31 | $14.0M |
| Q2 2022 | 35 | $16.4M |
| Q1 2022 | 45 | $35.3M |
| Q4 2021 | 40 | $119.8M |
| Q3 2021 | 35 | $331.1M |
| Q2 2021 | 33 | $261.4M |
| Q1 2021 | 47 | $218.9M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Landos Biopharma, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 14,869,915 | $217.1M | 3.16% | 00.0% | Unchanged |
| RTW Investments, LP | 4,275,722 | $62.4M | 0.94% | 00.0% | Unchanged |
| Logos Global Management LP | 1,405,000 | $20.5M | 1.48% | +505,894+56.3% | Added |
| JPMorgan Chase & Co | 309,992 | $4.53M | 0.00% | −64,838−17.3% | Reduced |
| Vanguard Group Inc | 304,794 | $4.45M | 0.00% | −391−0.1% | Reduced |
| OrbiMed Advisors LLC | 283,217 | $4.13M | 0.05% | −397,783−58.4% | Reduced |
| BlackRock Inc. | 233,616 | $3.41M | 0.00% | −60,427−20.6% | Reduced |
| Woodline Partners LP | 212,800 | $3.11M | 0.05% | −535−0.3% | Reduced |
| Macquarie Group Ltd | 147,182 | $2.15M | 0.00% | 00.0% | Unchanged |
| Botty Investors LLC | 128,750 | $1.88M | 0.56% | +5,969+4.9% | Added |
| Ensign Peak Advisors, Inc | 125,000 | $1.82M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 112,933 | $1.65M | 0.00% | −14,585−11.4% | Reduced |
| State Street Corp | 107,566 | $1.57M | 0.00% | +15,199+16.5% | Added |
| Northern Trust Corp | 46,680 | $682.0K | 0.00% | −27,239−36.8% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 18,831 | $275.0K | 0.00% | +18,831 | New |
| Jacobs Levy Equity Management, Inc | 18,174 | $265.0K | 0.00% | +18,174 | New |
| Bank of New York Mellon Corp | 14,953 | $218.0K | 0.00% | +924+6.6% | Added |
| Charles Schwab Investment Management Inc | 13,960 | $204.0K | 0.00% | +518+3.9% | Added |
| STRS Ohio | 11,400 | $166.0K | 0.00% | +9,900+660.0% | Added |
| Renaissance Technologies LLC | 10,900 | $159.0K | 0.00% | +10,900 | New |
| Allworth Financial LP | 5,286 | $77.0K | 0.00% | +5,286 | New |
| New York State Common Retirement Fund | 2,756 | $40.0K | 0.00% | −4,600−62.5% | Reduced |
| Deutsche Bank AG | 2,693 | $39.0K | 0.00% | −1,156−30.0% | Reduced |
| California State Teachers Retirement System | 2,530 | $37.0K | 0.00% | −6,431−71.8% | Reduced |
| American International Group, Inc. | 2,563 | $37.0K | 0.00% | −1,058−29.2% | Reduced |
| Morgan Stanley | 1,743 | $26.0K | 0.00% | −5,169−74.8% | Reduced |
| Bank of America Corp | 1,486 | $22.0K | 0.00% | −9,737−86.8% | Reduced |
| Geneos Wealth Management Inc. | 1,100 | $16.0K | 0.00% | +1,000+1,000.0% | Added |
| Tower Research Capital LLC (TRC) | 652 | $10.0K | 0.00% | −778−54.4% | Reduced |
| Royal Bank of Canada | 619 | $9.00K | 0.00% | +176+39.7% | Added |
| Ameritas Investment Partners, Inc. | 515 | $8.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 548 | $8.00K | 0.00% | +241+78.5% | Added |
| Legal & General Group Plc | 408 | $6.00K | 0.00% | −181−30.7% | Reduced |
| Carroll Financial Associates, Inc. | 393 | $5.00K | 0.00% | +343+686.0% | Added |
| Cahill Financial Advisors Inc | 100 | $1.00K | 0.00% | +100 | New |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −17,793−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −10,219−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −9,526−100.0% | Sold out |